Indiana University Research & Technology Corporation
发明人:
申请号：
EP15855548.2
公开号：
EP3213072A4
申请日:
2015.10.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Disclosed are biomarker panels for evaluating subjects at risk of sinusoidal obstruction syndrome (SOS) early after hematopoietic stem cell transplantation (HSCT). In particular, the present disclosure relates to the use of one or more of ST2, ANG2, L-Ficolin, HA, and VCAM1 for prognosing, diagnosing, and/or treating SOS.
